Curran, Nancy

Curran, Nancy was paid $350K by Medicaid between Feb 2018 and Nov 2024, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.

33Billing provider infoCURRAN, NANCY
BOSTON, MA 02118

33aNPI1659814036assigned 12/02/2016

33bProvider typeGerontology Nurse Practitioner

28Total paid$350K

24GClaims5,892

24DCodes billed5

24AFirst – last monthFeb 2018 – Nov 2024

Compared with peers

Next to other Gerontology Nurse Practitioner providers in Massachusetts

Rank by total paid#2 of 12

Median peer was paid$16K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	312	$18K
2019	542	$29K
2020	742	$38K
2021	929	$66K
2022	1,976	$117K
2023	1,048	$62K
2024incomplete	343	$19K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	41%	1,603	1,047	$144K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	33%	2,728	1,754	$115K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	22%	1,277	981	$76K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	3.5%	218	202	$12K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	66	57	$2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.